DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the PE ratio of Patel Chem Specialities Ltd?

Patel Chem Specialities Ltd has a price-to-earnings (PE) ratio of 19.0 in the Chemicals sector.

What is the market capitalisation of Patel Chem Specialities Ltd?

Patel Chem Specialities Ltd has a market capitalisation of approximately ₹239 crore.

Patel Chem Specialities Ltd

PATELCHEMSPECIALITIESLTD·NSE·Chemicals

₹0.00▲ +0.00 (+0.00%)

⚠️Trading suspended. Not a live price.

Chemicals · Specialty Chemicals

A steady, established business

52W₹56

₹121-87%

Open

—

High

—

Low

—

Prev Close

—

Volume

—

VWAP

—

Snapshot

Key fundamentals

Market Cap

₹239 Cr

P/E Ratio

19.00Fair

P/B Ratio

2.40

EPS

₹5.91

Book Value

₹40.01

ROE

18.60%Strong

ROCE

35.00%Efficient

Dividend Yield

0.00%

Debt / Equity

0.15Low

Face Value

₹10.00

52W High

₹120.89

52W Low

₹56.10

Sector

Chemicals

Industry

Specialty Chemicals

Fairly Valued

Narrow moatHigh uncertainty

Fair value estimate

₹79

No recent traded price

BearFair valueBull

₹67₹79₹91

/100

Business quality — Solid

Growth 50Profitability 58Efficiency 100Valuation 85

Plain English

Our view

A steady, established business
Low debt relative to equity

Strengths

Low debt relative to equity
Capital is working hard (ROCE 35%)
Promoters hold a controlling stake

How we got there

Fair value methods

Residual income

30% ROE fading to 13% over ~10 yrs, on ₹40 book

₹84

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹67

Analyst target

No analyst coverage

—

Blended fair value₹79

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Capital is working hard (ROCE 35%)
Promoters hold a controlling stake

Bear case

No notable red flags from the current metrics.

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

19.0Fair

Below 15× is value territory; above 35× prices in strong growth

ROE

18.6%Strong

Above 15% is considered healthy for Indian equities

ROCE

35.0%Efficient

Above 18% means capital is working hard

Debt/Eq

0.15Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹239 Cr

P/B

2.40

EPS

₹5.91

Div Yield

—

What changed

Recent changes

Foreign investors-1.8% stake last quarter
Domestic institutions-0.1% stake last quarter
Promoters+0.28% stake last quarter

What matters

News impact

Overview

Valuation

Reasonable

P/E 19.0×

Growth

Strong

+26% rev CAGR

Profitability

Excellent

18.6% ROE

Financial health

Rock solid

D/E 0.15

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover—

Trades—

VWAP—

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+25.8%

+26.7%

10Y

—

Profit

+60.5%

+65.5%

10Y

—

EPS

—

10Y

—

Profile

Pros

Company has delivered good profit growth of 56.9% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 27.8%

Watch-outs

Cons

Though the company is reporting repeated profits, it is not paying out dividend

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters raised their stake by 0.28 pts; foreign investors sold 1.78 pts; domestic institutions reduced 0.11 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

69%

Promoter

Promoters

68.6%+0.28

Public

16.4%+2.93

FII / FPI

6.4%-1.78

DII

1.7%-0.11

Others

6.9%

Total shareholders

1,089+165 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter68.64%

FII6.41%

DII1.70%

Public16.36%

Others6.89%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 2008, Patel Chem Specialities Limited (PCSL) is engaged in the manufacturing and exporting of pharmaceutical excipients and specialty chemicals.[1]